Relmada Therapeutics, Inc. (RLMD)
2.615
-0.50
(-15.92%)
USD |
NASDAQ |
Nov 20, 15:59
Relmada Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| February 28, 2014 | -442.9% |
| September 30, 2013 | |
| August 31, 2013 | |
| May 31, 2013 | -3.25K% |
| February 28, 2013 | -178.3% |
| Date | Value |
|---|---|
| November 30, 2012 | -428.6% |
| August 31, 2012 | -573.3% |
| May 31, 2012 | -625.0% |
| February 29, 2012 | -8.33% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Talphera, Inc. | -- |
| Journey Medical Corp. | -6.93% |
| ANI Pharmaceuticals, Inc. | 11.25% |
| Corcept Therapeutics, Inc. | 36.56% |
| Veru, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -45.94% |
| Return on Assets | -42.74% |
| Return on Invested Capital | -45.94% |
| Return on Net Operating Assets | -4.36K% |